Small-molecule inhibitor which reactivates p53 in human T-cell leukemia virus type 1-transformed cells

Journal of Virology

Volumn 82, Issue 17, 2008, Pages 8537-8547

  Jung, Kyung Jin ^a   Dasgupta, Arindam ^a   Huang, Keven ^a   Jeong, Soo Jin ^a   Pise Masison, Cynthia ^a   Gurova, Katerina V ^b   Brady, John N ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b CLEVELAND BIOLABS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOACRIDINE; PROTEIN P53;

ARTICLE; CELL CYCLE G1 PHASE; CELL TRANSFORMATION; CELL VIABILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; NICK END LABELING; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN FUNCTION;

AMINACRINE; ANTICARCINOGENIC AGENTS; APOPTOSIS; CELL CYCLE; CELL DEATH; CELL LINE, TRANSFORMED; CELL SURVIVAL; CELL TRANSFORMATION, VIRAL; DOSE-RESPONSE RELATIONSHIP, DRUG; G1 PHASE; GENES, REPORTER; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; IN SITU NICK-END LABELING; LUCIFERASES; NF-KAPPA B; PLASMIDS; RNA, SMALL INTERFERING; TIME FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 50149108780     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00690-08     Document Type: Article

References (49)

1. Akagi, T., H. Ono, and K. Shimotohno. 1995. Characterization of T cells immortalized by Taxi of human T-cell leukemia virus type 1. Blood 86:4243-4249.
2. Asquith, B., A. J. Mosley, A. Heaps, Y. Tanaka, G. P. Taylor, A. R. McLean, and C. R. Bangham. 2005. Quantification of the virus-host interaction in human T lymphotropic virus I infection. Retrovirology 2:75.
3. Bangham, C. R., and M. Osame. 2005. Cellular immune response to HTLV-1. Oncogene 24:6035-6046.
4. Bex, F., and R. B. Gaynor. 1998. Regulation of gene expression by HTLV-I Tax protein. Methods 16:83-94.
5. Datta, A., M. Bellon, U. Sinha-Datta, A. Bazarbachi, Y. Lepelletier, D. Canioni, T. A. Waldmann, O. Hermine, and C. Nicot. 2006. Persistent inhibition of telomerase reprograms adult T-cell leukemia to p53-dependent senescence. Blood 108:1021-1029.
6. Datta, S. R., A. Brunet, and M. E. Greenberg. 1999. Cellular survival: a play in three Akts. Genes Dev. 13:2905-2927.
7. de La Fuente, C., L. Deng, F. Santiago, L. Arce, L. Wang, and F. Kashanchi. 2000. Gene expression array of HTLV type 1-infected T cells: up-regulation of transcription factors and cell cycle genes. AIDS Res. Hum. Retrovir. 16:1695-1700.
8. Grassmann, R., C. Dengler, I. Muller-Fleckenstein, B. Fleckenstein, K. McGuire, M. C. Dokhelar, J. G. Sodroski, and W. A. Haseltine. 1989. Transformation to continuous growth of primary human T lymphocytes by human T-cell leukemia virus type I X-region genes transduced by a herpesvirus Saimiri vector. Proc. Natl. Acad. Sci. USA 86:3351-3355.
9. Grossman, W. J., J. T. Kimata, F. H. Wong, M. Zutter, T. J. Ley, and L. Ratner. 1995. Development of leukemia in mice transgenic for the tax gene of human T-cell leukemia virus type I. Proc. Natl. Acad. Sci. USA 92:1057-1061.
10. Gurova, K. V., J. E. Hill, C. Guo, A. Prokvolit, L. G. Burdelya, E. Samoylova, A. V. Khodyakova, R. Ganapathi, M. Ganapathi, N. D. Tararova, D. Bosykh, D. Lvovskiy, T. R. Webb, G. R. Stark, and A. V. Gudkov. 2005. Small molecules that reactivate p53 in renal cell carcinoma reveal a NF-κB-dependent mechanism of p53 suppression in tumors. Proc. Natl. Acad. Sci. USA 102:17448-17453.
11. Hasegawa, H., H. Sawa, M. J. Lewis, Y. Orba, N. Sheehy, Y. Yamamoto, T. Ichinohe, Y. Tsunetsugu-Yokota, H. Katano, H. Takahashi, J. Matsuda, T. Sata, T. Kurata, K. Nagashima, and W. W. Hall. 2006. Thymus-derived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I. Nat. Med. 12:466-472.
12. Hinrichs, S. H., M. Nerenberg, R. K. Reynolds, G. Khoury, and G. Jay. 1987. A transgenic mouse model for human neurofibromatosis. Science 237:1340-1343.
13. Hiscott, J., H. Kwon, and P. Genin. 2001. Hostile takeovers: viral appropriation of the NF-κB pathway. J. Clin. Investig. 107:143-151.
14. Jeang, K. T. 2001. Functional activities of the human T-cell leukemia virus type I Tax oncoprotein: cellular signaling through NF-κB. Cytokine Growth Factor Rev. 12:207-217.
15. Jeang, K. T., C. Z. Giam, F. Majone, and M. Aboud. 2004. Life, death, and tax: role of HTLV-I oncoprotein in genetic instability and cellular transformation. J. Biol. Chem. 279:31991-31994.
16. Jeong, S. J., A. Dasgupta, K. J. Jung, J. H. Um, A. Burke, H. U. Park, and J. N. Brady. 2008. PI3K/AKT inhibition induces caspase-dependent apoptosis in HTLV-1-transformed cells. Virology 370:264-272.
17. Jeong, S. J., C. A. Pise-Masison, M. F. Radonovich, H. U. Park, and J. N. Brady. 2005. Activated AKT regulates NF-κB activation, p53 inhibition and cell survival in HTLV-1-transformed cells. Oncogene 24:6719-6728.
18. Jeong, S. J., M. Radonovich, J. N. Brady, and C. A. Pise-Masison. 2004. HTLV-I Tax induces a novel interaction between p65/RelA and p53 that results in inhibition of p53 transcriptional activity. Blood 104:1490-1497.
19. Jiang, X., N. Takahashi, N. Matsui, T. Tetsuka, and T. Okamoto. 2003. The NF-κB activation in lymphotoxin beta receptor signaling depends on the phosphorylation of p65 at serine 536. J. Biol. Chem. 278:919-926.
20. Kehn, K., R. Berro, C. de la Fuente, K. Strouss, E. Ghedin, S. Dadgar, M. E. Bottazzi, A. Pumfery, and F. Kashanchi. 2004. Mechanisms of HTLV-1 transformation. Front Biosci. 9:2347-2372.
21. Kerkhofs, P., H. Heremans, A. Burny, R. Kettmann, and L. Willems. 1998. In vitro and in vivo oncogenic potential of bovine leukemia virus G4 protein. J. Virol. 72:2554-2559.
22. Kim, S. J., T. S. Winokur, H. D. Lee, D. Danielpour, K. Y. Kim, A. G. Geiser, L. S. Chen, M. B. Sporn, A. B. Roberts, and G. Jay. 1991. Overexpression of transforming growth factor-beta in transgenic mice carrying the human T-cell lymphotropic virus type I tax gene. Mol. Cell. Biol. 11:5222-5228.
23. Madrid, L. V., M. W. Mayo, J. Y. Reuther, and A. S. Baldwin, Jr. 2001. Akt stimulates the transactivation potential of the RelA/p65 subunit of NF-κB through utilization of the IκB kinase and activation of the mitogen-activated protein kinase p38. J. Biol. Chem. 276:18934-18940.
24. Mayo, L. D., and D. B. Donner. 2002. The PTEN, Mdm2, p53 tumor suppressor-oncoprotein network. Trends Biochem. Sci. 27:462-467.
25. Nerenberg, M., S. H. Hinrichs, R. K. Reynolds, G. Khoury, and G. Jay. 1987. The tat gene of human T-lymphotropic virus type 1 induces mesenchymal tumors in transgenic mice. Science 237:1324-1329.
26. Okamoto, T., Y. Ohno, S. Tsugane, S. Watanabe, M. Shimoyama, K. Tajima, M. Miwa, and K. Shimotohno. 1989. Multi-step carcinogenesis model for adult T-cell leukemia. Jpn. J. Cancer Res. 80:191-195.
27. O'Mahony, A. M., M. Montano, K. Van Beneden, L. F. Chen, and W. C. Greene. 2004. Human T-cell lymphotropic virus type 1 tax induction of biologically Active NF-κB requires IκB kinase-1-mediated phosphorylation of RelA/p65. J. Biol. Chem. 279:18137-18145.
28. Orlowski, R. Z., and A. S. Baldwin, Jr. 2002. NF-κB as a therapeutic target in cancer. Trends Mol. Med. 8:385-389.
29. Oya, M., A. Takayanagi, A. Horiguchi, R. Mizuno, M. Ohtsubo, K. Marumo, N. Shimizu, and M. Murai. 2003. Increased nuclear factor-kappa B activation is related to the tumor development of renal cell carcinoma. Carcinogenesis 24:377-384.
30. Ozes, O. N., L. D. Mayo, J. A. Gustin, S. R. Pfeffer, L. M. Pfeffer, and D. B. Donner. 1999. NF-κB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401:82-85.
31. Peloponese, J. M., Jr., and K. T. Jeang. 2006. Role for Akt/protein kinase B and activator protcin-1 in cellular proliferation induced by the human T-cell leukemia virus type 1 tax oncoprotein. J. Biol. Chem. 281:8927-8938.
32. Pise-Masison, C. A., and J. N. Brady. 2005. Setting the stage for transformation: HTLV-1 Tax inhibition of p53 function. Front. Biosci. 10:919-930.
33. Pise-Masison, C. A., S. J. Jeong, and J. N. Brady. 2005. Human T cell leukemia virus type 1: the role of Tax in leukemogcnesis. Arch. Immunol. Ther. Exp. 53:283-296.
34. Pise-Masison, C. A., R. Mahieux, H. Jiang, M. Ashcroft, M. Radonovich, J. Duvall, C. Guillerm, and J. N. Brady. 2000. Inactivation of p53 by human T-cell lymphotropic virus type 1 Tax requires activation of the NF-κB pathway and is dependent on p53 phosphorylation. Mol. Cell. Biol. 20:3377-3386.
35. Pise-Masison, C. A., R. Mahieux, M. Radonovich, H. Jiang, and J. N. Brady. 2001. Human T-lymphotropic virus type I Tax protein utilizes distinct pathways for p53 inhibition that are cell type-dependent. J. Biol. Chem. 276:200-205.
36. Pozzatti, R., J. Vogel, and G. Jay. 1990. The human T-lymphotropic virus type I tax gene can cooperate with the ras oncogene to induce neoplastic transformation of cells. Mol. Cell. Biol. 10:413-417.
37. Prives, C., and P. A. Hall. 1999. The p53 pathway. J. Pathol. 187:112-126.
38. Ratner, L., T. Portis, M. Robek, J. Harding, and W. Grossman. 2000. Studies of the immortalizing activity of HTLV type 1 Tax, using an infectious molecular clone and transgenic mice. AIDS Res. Hum Retrovir. 16:1647-1651.
39. Romashkova, J. A., and S. S. Makarov. 1999. NF-κB is a target of AKT in anti-apoptotic PDGF signalling. Nature 401:86-90.
40. Sakurai, H., H. Chiba, H. Miyoshi, T. Sugita, and W. Toriumi. 1999. IκB kinases phosphorylate NF-κB p65 subunit on serine 536 in the transactivation domain. J. Biol. Chem. 274:30353-30356.
41. Sizemore, N., S. Leung, and G. R. Stark. 1999. Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-κB p65/RelA subunit. Mol. Cell. Biol. 19:4798-4805.
42. Stark, M. M., N. C. Hall, R. J. Nicholson, and K. Soelberg. 1968. 9-Aminoacridine, an effective antibacterial agent with caries-disclosing features. Oral. Surg. Oral. Med. Oral Pathol. 26:560-562.
43. Steven, F. S., U. Suresh, T. L. Wong, and M. M. Griffin. 1987. The role of inhibitors in the fluorescent staining of benign naevus and malignant melanoma cells with 9-amino acridinc and acridine orange. J. Enzyme Inhib. 1:275-287.
44. Tanaka, A., C. Takahashi, S. Yamaoka, T. Nosaka, M. Maki, and M. Hatanaka. 1990. Oncogenic transformation by the tax gene of human T-cell leukemia virus type I in vitro. Proc. Natl. Acad. Sci. USA 87:1071-1075.
45. Vogelstein, B., D. Lane, and A. J. Levine. 2000. Surfing the p53 network. Nature 408:307-310.
46. Vousden, K. H., and X. Lu. 2002. Live or let die: the cell's response to p53. Nat. Rev. Cancer 2:594-604.
47. Wainwright, M. 2001. Acridine-a neglected antibacterial chromophore. J. Antimicrob. Chemother. 47:1-13.
48. Wu, W., K. Kehn-Hall, C. Pedati, L. Zweier, I. Castro, Z. Klase, C. S. Dowd, L. Dubrovsky, M. Bukrinsky, and F. Kashanchi. 2008. Drug 9AA reactivates p21/Waf1 and Inhibits HIV-1 progeny formation. Virol. J. 5:41.
49. Yoshida, M. 2001. Multiple viral strategies of HTLV-1 for dysregulation of cell growth control. Annu. Rev. Immunol. 19:475-496.